{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T04:34:07Z","timestamp":1649046847562},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,7,8]],"date-time":"2012-07-08T00:00:00Z","timestamp":1341705600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1476-511x-11-89","type":"journal-article","created":{"date-parts":[[2012,7,8]],"date-time":"2012-07-08T18:14:15Z","timestamp":1341771255000},"source":"Crossref","is-referenced-by-count":5,"title":["Platelet activating factor levels and metabolism in tangier disease: a case study"],"prefix":"10.1186","volume":"11","author":[{"given":"Vana","family":"Kolovou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki D","family":"Papakonstantinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Stamatakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia N","family":"Verouti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna N","family":"Xanthopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genovefa","family":"Kolovou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantinos A","family":"Demopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,8]]},"reference":[{"key":"767_CR1","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.7326\/0003-4819-55-6-1016","volume":"55","author":"DS Fredrickson","year":"1961","unstructured":"Fredrickson DS, Altrocehi PH, Avioli LV, Goodman DWS, Goodman HC: Tangier disease. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med. 1961, 55: 1016-1031.","journal-title":"Ann Intern Med"},{"key":"767_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/11905","volume":"22","author":"A Brooks-Wilson","year":"1999","unstructured":"Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, Loubser O, Ouelette BF, Fichter K, Ashbourne-Excoffon KJ, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJ, Genest J, Hayden MR: Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet. 1999, 22: 336-345. 10.1038\/11905","journal-title":"Nat Genet"},{"key":"767_CR3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/11921","volume":"22","author":"S Rust","year":"1999","unstructured":"Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Den\u00e8fle P, Assmann G: Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet. 1999, 22: 352-355. 10.1038\/11921","journal-title":"Nat Genet"},{"key":"767_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/11914","volume":"22","author":"M Bodzioch","year":"1999","unstructured":"Bodzioch M, Ors\u00f3 E, Klucken J, Langmann T, B\u00f6ttcher A, Diederich W, Drobnik W, Barlage S, B\u00fcchler C, Porsch-Ozc\u00fcr\u00fcmez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G: The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet. 1999, 22: 347-351. 10.1038\/11914","journal-title":"Nat Genet"},{"key":"767_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1006\/bbrc.1999.0406","volume":"257","author":"T Langmann","year":"1999","unstructured":"Langmann T, Klucken J, Reil M, Liebisch G, Luciani MF, Chimini G, Kaminski WE, Schmitz G: Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun. 1999, 257: 29-33. 10.1006\/bbrc.1999.0406","journal-title":"Biochem Biophys Res Commun"},{"key":"767_CR6","doi-asserted-by":"publisher","first-page":"28634","DOI":"10.1074\/jbc.M003407200","volume":"275","author":"AE Bortnick","year":"2000","unstructured":"Bortnick AE, Rothblat GH, Stoudt G, Hoppe KL, Royer LJ, McNeish J, Francone OL: The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem. 2000, 275: 28634-28640.","journal-title":"J Biol Chem"},{"key":"767_CR7","first-page":"173","volume":"168","author":"JF Oram","year":"2002","unstructured":"Oram JF: Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1. Trends Mol Med. 2002, 168: 173-Review,","journal-title":"Trends Mol Med"},{"key":"767_CR8","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2174\/092986706776055580","volume":"13","author":"GD Kolovou","year":"2006","unstructured":"Kolovou GD, Mikhailidis DP, Anagnostopoulou KK, Daskalopoulou SS, Cokkinos DV: Tangier disease four decades of research: a reflection of the importance of HDL. Curr Med Chem. 2006, 13: 771-782. Review, 10.2174\/092986706776055580","journal-title":"Curr Med Chem"},{"key":"767_CR9","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1194\/jlr.M300086-JLR200","volume":"44","author":"S Blankenberg","year":"2003","unstructured":"Blankenberg S, Stengel D, Rupprecht HJ, Bickel C, Meyer J, Cambien F, Tiret L, Ninio E: Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis. J Lipid Res. 2003, 44: 1381-1386. 10.1194\/jlr.M300086-JLR200","journal-title":"J Lipid Res"},{"key":"767_CR10","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.1016\/S0021-9258(19)83523-8","volume":"254","author":"CA Demopoulos","year":"1979","unstructured":"Demopoulos CA, Pinckard RN, Hanahan DJ: Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as tha active component (a new class of lipid chemical mediators). J Biol Chem. 1979, 254: 9355-9358.","journal-title":"J Biol Chem"},{"key":"767_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1432-1033.1996.00048.x","volume":"236","author":"C Dentan","year":"1996","unstructured":"Dentan C, Lesnik P, Chapman MJ, Ninio E: Phagocytic activation induces formation of platelet-activating factor in human monocyte-derived macrophages and in macrophage-derived foam cells: relevance to the inflammatory reaction in atherogenesis. Eur J Biochem. 1996, 236: 48-55. 10.1111\/j.1432-1033.1996.00048.x","journal-title":"Eur J Biochem"},{"key":"767_CR12","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ejlt.200300845","volume":"105","author":"CA Demopoulos","year":"2003","unstructured":"Demopoulos CA, Karantonis HC, Antonopoulou S: Platelet activating factor- A molecular link between atherosclerosis theories. Eur J Lipid Sci Tech. 2003, 105: 705-716. 10.1002\/ejlt.200300845.","journal-title":"Eur J Lipid Sci Tech"},{"key":"767_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2174\/1573401310703040255","volume":"3","author":"T Nomikos","year":"2007","unstructured":"Nomikos T, Fragopoulou E, Antonopoulou S: Food ingredients and lipid mediators. Curr Nutr Food Sci. 2007, 3: 255-276.","journal-title":"Curr Nutr Food Sci"},{"key":"767_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10557-008-6133-8","volume":"223","author":"DM Stafforini","year":"2009","unstructured":"Stafforini DM: Biology of platelet-activating factor acetyhydrolase (PAF-AH), lipoprotein-associated phospholipase A2. Cardiovasc Drugs Ther. 2009, 223: 73-83.","journal-title":"Cardiovasc Drugs Ther"},{"key":"767_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1476-511X-8-19","volume":"8","author":"P Detopoulou","year":"2009","unstructured":"Detopoulou P, Nomikos T, Fragopoulou E, Panagiotakos DB, Pitsavos C, Stefanadis C, Antonopoulou S: Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetyhydrolase (PAF-AH) in leukocytes and body composition in healthy adults. Lipidis in Health and Disease. 2009, 8: 19-10.1186\/1476-511X-8-19. 10.1186\/1476-511X-8-19","journal-title":"Lipidis in Health and Disease"},{"key":"767_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1034\/j.1399-0004.2003.00056.x","volume":"63","author":"GD Kolovou","year":"2003","unstructured":"Kolovou GD, Wade DP, Sengupta R, Cokkinos DV: Tangier disease with unusual clinical manifestations. Clin Genet. 2003, 63: 323-324. 10.1034\/j.1399-0004.2003.00056.x","journal-title":"Clin Genet"},{"key":"767_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0021-9150(03)00151-5","volume":"169","author":"G Kolovou","year":"2003","unstructured":"Kolovou G, Anagnostopoulou K, Cokkinos DV: A new ABCA1 mutation associated with low HDL cholesterol but without coronary artery disease. Atherosclerosis. 2003, 169: 345-346. 10.1016\/S0021-9150(03)00151-5","journal-title":"Atherosclerosis"},{"key":"767_CR18","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/jcp.56.12.937","volume":"56","author":"G Kolovou","year":"2003","unstructured":"Kolovou G, Daskalova D, Anagnostopoulou K, Hoursalas I, Voudris V, Mikhailidis DP, Cokkinos DV: Postprandial hypertriglyceridaemia in patients with Tangier disease. J Clin Pathol. 2003, 56: 937-941. 10.1136\/jcp.56.12.937","journal-title":"J Clin Pathol"},{"key":"767_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/0003319710375089","volume":"62","author":"N Tsantila","year":"2011","unstructured":"Tsantila N, Tsoupras AB, Fragopoulou E, Antonopoulou S, Iatrou C, Demopoulos CA: In Vitro and In Vivo Effects of Statins on Platelet-Activating Factor and Its Metabolism. Angiology. 2011, 62: 209-218. 10.1177\/0003319710375089","journal-title":"Angiology"},{"key":"767_CR20","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1089\/aid.2007.0263","volume":"24","author":"AB Tsoupras","year":"2008","unstructured":"Tsoupras AB, Chini M, Tsogas N: Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection?. AIDS Res Hum Retroviruses. 2008, 24: 1079-1086. 10.1089\/aid.2007.0263","journal-title":"AIDS Res Hum Retroviruses"},{"key":"767_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.numecd.2005.07.003","volume":"16","author":"HC Karantonis","year":"2006","unstructured":"Karantonis HC, Antonopoulou S, Perrea DN, Sokolis DP, Theocharis SE, Kavantzas N, Iliopoulos DG, Demopoulos CA: In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits. Nutr Metab Cardiovasc Dis. 2006, 16: 174-185. 10.1016\/j.numecd.2005.07.003","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"767_CR22","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.numecd.2009.06.008","volume":"20","author":"N Tsantila","year":"2010","unstructured":"Tsantila N, Karantonis HC, Perrea DN, Theocharis SE, Iliopoulos DG, Iatrou C, Antonopoulou S, Demopoulos CA: Atherosclerosis regression study in rabbits upon olive pomace polar lipid extract administration. Nutr Metab Cardiovasc Dis. 2010, 20: 740-747. 10.1016\/j.numecd.2009.06.008","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"767_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/BF02536336","volume":"29","author":"CA Demopoulos","year":"1994","unstructured":"Demopoulos CA, Andrikopoulos NK, Antonopoulou S: A simple and precise method for the routine determination of platelet-activating factor in blood and urine. Lipids. 1994, 29: 305-309. 10.1007\/BF02536336","journal-title":"Lipids"},{"key":"767_CR24","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/o59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology. 1959, 37: 911-917. 10.1139\/o59-099","journal-title":"Canadian Journal of Biochemistry and Physiology"},{"key":"767_CR25","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/0020-711X(94)90138-4","volume":"26","author":"S Antonopoulou","year":"1994","unstructured":"Antonopoulou S, Demopoulos CA, Iatrou C, Moustakas G, Zirogiannis P: Platelet-activating-factor acetylhydrolase (Paf-Ah) in human kidney. Int J Biochem. 1994, 26: 1157-1162. 10.1016\/0020-711X(94)90138-4","journal-title":"Int J Biochem"},{"key":"767_CR26","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1155\/2007\/27683","volume":"2007","author":"AB Tsoupras","year":"2007","unstructured":"Tsoupras AB, Fragopoulou E, Nomikos T, Iatrou C, Antonopoulou S, Demopoulos CA: Characterization of the de novo biosynthetic enzyme of platelet activating factor, DDTinsensitive cholinephosphotransferase, of human mesangial cells. Mediators Inflam. 2007, 2007: 276-283.","journal-title":"Mediators Inflam"},{"key":"767_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00784-009-0346-5","volume":"14","author":"H Chen","year":"2010","unstructured":"Chen H, Zheng P, Zhu H, Zhu J, Zhao L, El Mokhtari NE, Eberhard J, Lins M, Jepsen S: Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and\/or coronary heart disease. Clin Oral Investig. 2010, 14: 629-636. 10.1007\/s00784-009-0346-5","journal-title":"Clin Oral Investig"},{"key":"767_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/09629350310001599666","volume":"12","author":"S Antonopoulou","year":"2003","unstructured":"Antonopoulou S, Tsoupras A, Baltas G, Kotsifaki H, Mantzavinos Z, Demopoulos CA: Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients. Mediators Inflamm. 2003, 12: 221-227. 10.1080\/09629350310001599666","journal-title":"Mediators Inflamm"},{"key":"767_CR29","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1600-051X.2006.00987.x","volume":"33","author":"P Zheng","year":"2006","unstructured":"Zheng P, Chen H, Shi S, Jepsen S, Eberhard J: Periodontal parameters and platelet-activating factor levels in serum and gingival crevicular fluid in a Chinese population. J Clin Periodontol. 2006, 33: 797-802. 10.1111\/j.1600-051X.2006.00987.x","journal-title":"J Clin Periodontol"},{"key":"767_CR30","first-page":"578","volume":"33","author":"F Gao","year":"2010","unstructured":"Gao F, Liu L, Li F: The levels of platelet-activating factor and nitric oxide synthase in bronchial asthma at high altitude [Article in Chinese]. Zhonghua Jie He He Hu Xi Za Zhi. 2010, 33: 578-581.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"767_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1056\/NEJMoa070030","volume":"358","author":"P Vadas","year":"2008","unstructured":"Vadas P, Gold M, Perelman B, Liss GM, Lack G, Blyth T, Simons FE, Simons KJ, Cass D, Yeung J: Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med. 2008, 358: 28-35. 10.1056\/NEJMoa070030","journal-title":"N Engl J Med"},{"key":"767_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.clinbiochem.2008.09.113","volume":"42","author":"P Detopoulou","year":"2009","unstructured":"Detopoulou P, Nomikos T, Fragopoulou E, Antonopoulou S, Kotroyiannis I, Vassiliadou C, Panagiotakos DB, Chrysohoou C, Pitsavos C, Stefanadis C: Platelet activating factor (PAF) and activity of its biosynthetic and catabolic enzymes in blood and leukocytes of male patients with newly diagnosed heart failure. Clin Biochem. 2009, 42: 44-49. 10.1016\/j.clinbiochem.2008.09.113","journal-title":"Clin Biochem"},{"key":"767_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0022-1759(93)90366-F","volume":"166","author":"J Sugatani","year":"1993","unstructured":"Sugatani J, Miwa M, Komiyama Y, Murakami T: Quantitative analysis of platelet-activating factor in human plasma. Application to patients with liver cirrhosis and disseminated intravascular coagulation. J Immunol Methods. 1993, 166: 251-261. 10.1016\/0022-1759(93)90366-F","journal-title":"J Immunol Methods"},{"key":"767_CR34","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1182\/blood.V66.6.1476.1476","volume":"66","author":"PH Pritchard","year":"1985","unstructured":"Pritchard PH, Chonn A, Yeung CCH: The degradation of Platelet-Activating Factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier Disease). Blood. 1985, 66: 1476-1478.","journal-title":"Blood"},{"key":"767_CR35","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1073\/pnas.86.7.2393","volume":"86","author":"DM Stafforini","year":"1989","unstructured":"Stafforini DM, Carter ME, Zimmerman GA, McIntyre TM, Prescott SM: Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma. Proc Natl Acad Sci. 1989, 86: 2393-2397. 10.1073\/pnas.86.7.2393","journal-title":"Proc Natl Acad Sci"},{"key":"767_CR36","first-page":"30","volume":"45","author":"DH Wan","year":"2010","unstructured":"Wan DH, Fan P, Bai H, Song Q, Liu HW: Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance [Article in Chinese]. Zhonghua Fu Chan Ke Za Zhi. 2010, 45: 30-34.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"767_CR37","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/S0026-0495(99)90240-8","volume":"48","author":"W Khovidhunkit","year":"1999","unstructured":"Khovidhunkit W, Memon RA, Shigenaga JK, Pang M, Schambelan M, Mulligan K, Feingold KR, Grunfeld C: Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism. 1999, 48: 1524-1531. 10.1016\/S0026-0495(99)90240-8","journal-title":"Metabolism"},{"key":"767_CR38","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/oxfordjournals.eurheartj.a061044","volume":"16","author":"J Goudevenos","year":"1995","unstructured":"Goudevenos J, Tselepis AD, Tsoukatos D, Grekas G, Kritikakos J, Sideris D: Platelet aggregability to platelet activating factor at rest and after exercise in patients with coronary artery disease. Eur Heart J. 1995, 16: 1036-1043.","journal-title":"Eur Heart J"},{"key":"767_CR39","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/0090-6980(89)90104-4","volume":"37","author":"K Satoh","year":"1989","unstructured":"Satoh K, Imaizumi T, Kawamura Y, Yoshida H, Takamatsu S, Takamatsu M: Increased activity of the platelet-activating factor acetylhydrolase in plasma low density lipoprotein from patients with essential hypertension. Prostaglandins. 1989, 37: 673-682. 10.1016\/0090-6980(89)90104-4","journal-title":"Prostaglandins"},{"key":"767_CR40","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1194\/jlr.M500389-JLR200","volume":"46","author":"ML Rufail","year":"2005","unstructured":"Rufail ML, Schenkein HA, Barbour SE, Tew JG, van Antwerpen R: Altered lipoprotein subclass distribution and PAF-AH activity in subjects with generalized aggressive periodontitis. J Lipid Res. 2005, 46: 2752-2760. 10.1194\/jlr.M500389-JLR200","journal-title":"J Lipid Res"},{"key":"767_CR41","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1600-051X.2005.00725.x","volume":"32","author":"W L\u00f6sche","year":"2005","unstructured":"L\u00f6sche W, Marshal GJ, Apatzidou DA, Krause S, Kocher T, Kinane DF: Lipoprotein-associated phospholipase A2 and plasma lipids in patients with destructive periodontal disease. J Clin Periodontol. 2005, 32: 640-644. 10.1111\/j.1600-051X.2005.00725.x","journal-title":"J Clin Periodontol"},{"key":"767_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000006831","volume":"90","author":"VL Serebruany","year":"1998","unstructured":"Serebruany VL, Gurbel PA, Murugesan SR, Lowry DR, Sturm E, Svetlov SI: Depressed plasma platelet-activating factor acetylhydrolase in patients presenting with acute myocardial infarction. Cardiology. 1998, 90: 127-130. 10.1159\/000006831","journal-title":"Cardiology"},{"key":"767_CR43","first-page":"119","volume":"3","author":"R Stathopoulou","year":"1990","unstructured":"Stathopoulou R, Kafalas A, Mantas J, Demopoulos CA, Sparos L: Normal values of PAF-induced platelet aggregation in healthy individuals. Hippokrates. 1990, 3: 119-124.","journal-title":"Hippokrates"},{"key":"767_CR44","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0008-6363(99)00078-4","volume":"43","author":"AD Tselepis","year":"1999","unstructured":"Tselepis AD, Goudevenos JA, Tambaki AP, Michalis L, Stroumbis CS, Tsoukatos DC, Elisaf M, Sideris DA: Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy. Cardiovasc Res. 1999, 43: 183-191. 10.1016\/S0008-6363(99)00078-4","journal-title":"Cardiovasc Res"},{"key":"767_CR45","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0020-711X(88)90099-7","volume":"20","author":"CA Demopoulos","year":"1988","unstructured":"Demopoulos CA, Andrikopoulos NK, Stathopoulou-Sparou R: Abnormal platelet response to PAF and ADP in beta-thalassaemia. Int J Biochem. 1988, 20: 599-604. 10.1016\/0020-711X(88)90099-7","journal-title":"Int J Biochem"},{"key":"767_CR46","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1182\/blood.V68.2.498.498","volume":"68","author":"JT Harmon","year":"1986","unstructured":"Harmon JT, Tandon NN, Hoeg JM, Jamieson GA: Thrombin binding and response in platelets from patients with dyslipoproteinemias: increased stimulus-response coupling in type II hyperlipoproteinemia. Blood. 1986, 68: 498-505.","journal-title":"Blood"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-511X-11-89.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1476-511X-11-89\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-511X-11-89.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T16:50:53Z","timestamp":1642697453000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/1476-511X-11-89"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,8]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["767"],"URL":"https:\/\/doi.org\/10.1186\/1476-511x-11-89","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,8]]},"article-number":"89"}}